Erica Rice

Partner, Co-Chair, Emerging Companies & Venture Capital Practice Group - Boston

Bio photo for Erica Rice
Download Media Photo

Contact Information

Erica Rice’s practice is focused on representing buyers and sellers in mergers and acquisitions and other strategic transactions, as well as counseling early and mid-stage companies regarding entity formation, founder’s arrangements, financings, exit strategies and general corporate governance. 

Erica’s clients include both public and private companies as well as venture capital investors. She also represents entrepreneurs as they develop their business plans and launch their companies. For these clients, Erica acts as a trusted advisor providing the specific legal guidance that they need at each stage of the company’s development. 

More »


  • Boston University School of Law, J.D., cum laude, 2010
  • University of Michigan, B.A., with high distinction, 2004

Representative Experience

Cannabis Industry

  • Global cannabis operator Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in multiple transactions, including:
    • its acquisition of vertically integrated cannabis company Medicine Man Denver for $42 million plus additional potential performance-based milestone payments
    • its $42.5 million acquisition of the Van de Wetering Greenhouses
    • its acquisition of Green Leaf Medical, LLC, a privately held, fully integrated cannabis multi-state operator based in the mid-Atlantic region, for approximately $240 million with the potential for additional performance-based milestone payments
    • its $69 million acquisition of Project Cannabis, a leading cannabis cultivator, wholesaler and retailer
    • its acquisition of The Green Solution (“TGS”), the largest vertically integrated cannabis operator in Colorado, through a transaction initially valued at approximately $140 million
    • its ultimate sale to Cresco Labs for $2 billion, in what is likely the largest transaction in cannabis history to date
  •  Cultivate Holdings in its sale to Cresco Labs (CSE:CL) (OTCQX:CRLBF), for upfront consideration equal to $90 million plus an earnout of up to $68 million.
  • Ascend Wellness Holdings, a multi-state, vertically integrated cannabis operator, in multiple transactions, including:
    • Its pending acquisition of an 86.7% interest in MedMed’s New York cannabis operations for approximately $73M, with an option to acquire the remaining equity of MMNY
    • its  acquisition of Greenleaf Compassion Center, a New Jersey vertically integrated cannabis company

Technology Industry

  • ProMerchant LLC, Cape Cod Merchant Services LLC and Flow Payments LLC, three players in the merchant processing solutions space, in their sale to Waitr Holdings Inc. (Nasdaq: WTRH)
  • Voatz, a mobile election voting application, in closing its Series A-1 financing, with participation from Apollo Projects, Medici Ventures, Techstars Ventures, Urban Innovation and Wanamaker Portfolio Trust
  • Shift4 Payments (NYSE: FOUR), in connection with its acquisition of VenueNext, a provider of integrated payment processing and 3dcart, an e-commerce platform
  • Digital financial company BlockFi, in closing its $37 million Series B financing
  • LevelUp, a leader in mobile diner engagement and payment solutions for restaurants, in its $390 million sale to online and mobile food-ordering and delivery marketplace Grubhub Inc.
  • Global cybersecurity leader RSA in its acquisition of Fortscale
  • L2, a digital brand researcher, in its acquisition by Gartner
  • CloudLock, a privately-held cloud security company, in its acquisition by Cisco
  • Pegasystems in its acquisition of OpenSpan
  • Resilient Systems in its acquisition by IBM
  • Viewfinity in its acquisition by CyberArk

Life Sciences & Healthcare Industry

  • AOA, a developer of non-invasive ovarian cancer diagnosis technology, in their $2.5 million convertible note financing
  • Kyruus, the leader in provider search and scheduling solutions for health systems, in its acquisition of HealthSparq from Cambia Health Solutions
  • AZTherapies, a late-stage clinical biopharmaceutical company developing treatments for devastating neurological conditions, in its $33.6 million Series C-1 financing
  • Orig3n, a biotech company focused on DNA testing, in its acquisition of Interleukin Genetics
  • Applied Genetic Technologies Corporation in its $52 million initial public offering and subsequent $30 million follow-on public offering
  • Thermo Fisher Scientific in its acquisition of MTI-GlobalStem


  • “Top Lawyer – Corporate Law,” Boston Magazine (2021)
  • Named a Law360 Rising Star, Cannabis category (2021)
  • Ranked by Venture Capital Journal as one of venture capital's 40 rising stars (2020) 
  • Ranked by Chambers USA: America's Leading Lawyers for Business as one of Massachusetts' leading Corporate/M&A attorneys (2016, 2017) 
  • Boston University Law Review, Administrative Editor


  • Boston Bar Association, Member 
  • Women’s Bar Association, Member
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts